CD4 and neoplasm: For melanoma, T-VEC was already demonstrated to increase the number of tumor infiltrating CD4- and CD8-lymphocytes as well as activated CD8-lympho-cytes in the circulation and to rise expression of PD-L1 and IFNγ in virus-injected tumors (16, 17).